针对类风湿性关节炎的纳米疗法:最近的专利和发展
Manish Makhija1,2, Deeksha Manchanda1,2, Manu Sharma1
1Department of Pharmacy, Banasthali Vidyapith, Rajasthan, 304022, India.
Recent patents on nanotechnology
|September 11, 2023
概括
纳米技术为风湿性关节炎 (RA) 治疗提供了有前途的进展,解决了传统疗法的局限性. 这种方法有效地准炎症,改善了这种慢性自身免疫性疾病的诊断和管理.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
- 类风湿病学 类风湿病学
背景情况:
- 风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,导致关节炎症,软骨损伤和残疾.
- 像IL-1,IL-6和IL-10这样的亲炎性细胞因子驱动RA炎症.
- 传统的RA治疗有显著的缺点,包括无效,高剂量,频繁的管理,成本和不良影响.
研究的目的:
- 探索纳米技术在改善类风湿性关节炎诊断和管理方面的潜力.
- 突出纳米配方的发展,用于针对性地在RA中提供抗炎药物.
主要方法:
- 审查当前的研究和临床试验数据纳米技术应用在RA.
- 对针对RA患者炎症区域的纳米配方的分析.
主要成果:
- 纳米药物在RA诊断和管理方面显示出显著的改善.
- 纳米配方提供针对性地提供抗炎活性药物成分 (API).
- 最近的进展包括许多专利和临床试验数据与RA纳米医学相关.
结论:
- 纳米技术为开发更有效的RA治疗提供了一个有希望的途径.
- 通过纳米医药的向治疗可以克服传统RA疗法的局限性.
- 持续的研究和临床试验对于充分实现纳米技术在RA护理中的潜力至关重要.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


